Cargando…
Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer
Weight loss and anorexia are common symptoms in cancer patients that occur prior to initiation of cancer therapy. Inflammation in the brain is a driver of these symptoms, yet cellular sources of neuroinflammation during malignancy are unknown. In a mouse model of pancreatic ductal adenocarcinoma (PD...
Autores principales: | Burfeind, Kevin G, Zhu, Xinxia, Norgard, Mason A, Levasseur, Peter R, Huisman, Christian, Buenafe, Abigail C, Olson, Brennan, Michaelis, Katherine A, Torres, Eileen RS, Jeng, Sophia, McWeeney, Shannon, Raber, Jacob, Marks, Daniel L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253193/ https://www.ncbi.nlm.nih.gov/pubmed/32391790 http://dx.doi.org/10.7554/eLife.54095 |
Ejemplares similares
-
Microglia in the hypothalamus respond to tumor‐derived factors and are protective against cachexia during pancreatic cancer
por: Burfeind, Kevin G., et al.
Publicado: (2020) -
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
por: Olson, Brennan, et al.
Publicado: (2021) -
Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia
por: Olson, Brennan, et al.
Publicado: (2021) -
Establishment and characterization of a novel murine model of pancreatic cancer cachexia
por: Michaelis, Katherine A., et al.
Publicado: (2017) -
MyD88 signalling is critical in the development of pancreatic cancer cachexia
por: Zhu, Xinxia, et al.
Publicado: (2019)